Economy
Financial Markets
Commodities
Industries
Energy
Real Estate
Local listed Company
Overseas-listed Company
Foreign Company
Industrial Parks


 
Financial Market
 Search News  Or
Taizhou Huaxin Medicine Inv’t to issue RMB 950 mln MTN

Sep. 17, 2012 (China Knowledge) - Taizhou Huaxin Medicine Investment Ltd, which is engaged in medicine development, real estate and infrastructure construction in Taizhou, Jiangsu Province, has announced it will issue RMB 950 million in medium-term notes with a maturity of five years in the interbank market on Sep 24.

The company said in a statement that the notes will be issued at face value, and the coupon rate determined in the process of book-building.

Both value and payment due date is set on Sep 26, and the to-be-issued notes tradable Sep 27.

All the proceeds from the issue will be used to repay bank loans, said the issuer.

Shanghai Brilliance Credit Rating & Investors Service Co Ltd has rated the issuer and notes AA and AA, respectively.

Huaxia Bank Co Ltd<600015> has been hired as lead underwriter and bookrunner. Shanghai Pudong Development Bank Co Ltd<600000> will be joint lead underwriter for the offering.







Add this     
Copyright © "2015" www.chinaknowledge.com

Send feedback or comments to: news@chinaknowledge.com

For more news, financial weekly reports, business guides to China, Market Research Reports and other premium information, subscribe to China Knowledge today

To access our page on Bloomberg, type CKFI (GO)

 Our Professional Services

 E-Store

 News Archive
About Us | CSR | Media Center | E-Newsletter | E-Store | Contact Us | Feedback | Sitemap | Privacy Policy | Terms of Use  

           Copyright © 2014 China Knowledge Online. All Rights Reserved